Central nervous system complications after transplantation.
暂无分享,去创建一个
[1] T. Gayowski,et al. Plasmapheresis and Intravenous Immune Globulin Improve Neurologic Outcome of Central Pontine Myelinolysis Occurring Post Orthotopic Liver Transplant , 2011, The Annals of pharmacotherapy.
[2] P. Gibbs,et al. Switching to Sirolimus-Based Immune Suppression After Liver Transplantation Is Safe and Effective: A Single-Center Experience , 2011, Transplantation.
[3] Jung Sun Kim,et al. Wernicke's encephalopathy following allogeneic hematopoietic stem cell transplantation , 2010, The Korean journal of hematology.
[4] S. Marasco,et al. Extracorporeal membrane oxygenation in primary graft failure after heart transplantation. , 2010, The Annals of thoracic surgery.
[5] Daniel Wolff,et al. Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease. , 2010, Brain : a journal of neurology.
[6] C. Gluud,et al. Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials , 2010, European Journal of Clinical Pharmacology.
[7] A. Gasbarrini,et al. Sirolimus in liver transplant recipients: a large single-center experience. , 2010, Transplantation proceedings.
[8] A. Straube,et al. Cerebral angiitis in four patients with chronic GVHD , 2010, Bone Marrow Transplantation.
[9] M. Rosner,et al. Osmotic Demyelination Syndrome , 2010, The American journal of the medical sciences.
[10] J. Guinea,et al. Infectious and Non-Infectious Neurologic Complications in Heart Transplant Recipients , 2010, Medicine.
[11] A. Rabinstein,et al. Neurological Complications Following Adult Lung Transplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[12] M. Baulac,et al. Incidence and risk factors for seizures after heart transplantation , 2010, Journal of Neurology.
[13] K. Abu-Elmagd,et al. The clinical spectrum of neurologic disorders after intestinal and multivisceral transplantation , 2010, Clinical transplantation.
[14] D. Schiff,et al. Primary central nervous system post‐transplantation lymphoproliferative disorder , 2010, Cancer.
[15] K. Akashi,et al. Encephalomyelitis mimicking multiple sclerosis associated with chronic graft-versus-host disease after allogeneic bone marrow transplantation. , 2009, Internal medicine.
[16] K. Lopau,et al. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. , 2009, JAMA.
[17] J. Ruiz-Morales,et al. Akinetic mutism induced by tacrolimus. , 2009, Clinical neuropharmacology.
[18] Zhong-wei Zhang,et al. Therapy of central pontine myelinolysis following living donor liver transplantation: Report of three cases. , 2009, World journal of gastroenterology.
[19] D. Broering,et al. Quality of life after liver transplantation. , 2009, Transplantation proceedings.
[20] W. Hiddemann,et al. Idiopathic hyperammonemia (IHA) after dose-dense induction chemotherapy for acute myeloid leukemia: Case report and review of the literature. , 2009, Leukemia research.
[21] K. McCurry,et al. Neurologic complications following lung transplantation , 2009, Journal of the Neurological Sciences.
[22] W. Kremers,et al. No Major Neurologic Complications With Sirolimus Use in Heart Transplant Recipients , 2009 .
[23] J. Katz,et al. Human herpesvirus 6 encephalitis , 2008, Current infectious disease reports.
[24] M. Haberal,et al. Neurologic complications after renal transplant. , 2008, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.
[25] J. Boardman,et al. Posterior Reversible Encephalopathy Syndrome after Solid Organ Transplantation , 2008, American Journal of Neuroradiology.
[26] M. Lucey,et al. Quality of life after liver transplantation. A systematic review. , 2008, Journal of hepatology.
[27] W. Kremers,et al. Effect of neurologic complications on outcome after heart transplant. , 2008, Archives of neurology.
[28] E. Wijdicks,et al. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. , 2008, Archives of neurology.
[29] E. Wijdicks,et al. Central nervous system infections in heart transplant recipients. , 2007, Archives of neurology.
[30] A. Rabinstein,et al. Tacrolimus induced leukoencephalopathy presenting with status epilepticus and prolonged coma , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[31] J. Lipton,et al. Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[32] G. Patterson,et al. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[33] B. Hainline,et al. Hyperammonemia in the ICU. , 2007, Chest.
[34] C. Bodkin,et al. SIROLIMUS-INDUCED POSTERIOR REVERSIBLE ENCEPHALOPATHY , 2007, Neurology.
[35] H. Karakayalı,et al. Tacrolimus-related seizure in the early postoperative period after liver transplantation. , 2007, Transplantation proceedings.
[36] E. Lis,et al. Posterior reversible encephalopathy syndrome due to sirolimus , 2007, Bone Marrow Transplantation.
[37] G. Ewald,et al. Significance of neurologic complications in the modern era of cardiac transplantation. , 2007, The Annals of thoracic surgery.
[38] C. Lacroix,et al. Spectrum and prognosis of neurologic complications after hematopoietic transplantation , 2006, Neurology.
[39] Arjun Srinivasan,et al. Transmission of lymphocytic choriomeningitis virus by organ transplantation. , 2006, The New England journal of medicine.
[40] Edward A Copelan,et al. Hematopoietic stem-cell transplantation. , 2006, The New England journal of medicine.
[41] H. Karakayalı,et al. Tacrolimus-related neurologic and renal complications in liver transplantation: A single-center experience. , 2006, Transplantation proceedings.
[42] J. Benito-León,et al. EFNS guidelines on management of neurological problems in liver transplantation , 2006, European journal of neurology.
[43] L. Martínez-Dolz,et al. Incidence of and risk factors for neurologic complications after heart transplantation. , 2005, Transplantation proceedings.
[44] A. Webster,et al. Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients. , 2005, The Cochrane database of systematic reviews.
[45] G. Ercolani,et al. Causes of early acute graft failure after liver transplantation: analysis of a 17‐year single‐centre experience , 2005, Clinical transplantation.
[46] P. Bergethon,et al. Levetiracetam for seizures after liver transplantation , 2005, Neurology.
[47] D. Cardo,et al. Transmission of rabies virus from an organ donor to four transplant recipients. , 2005, The New England journal of medicine.
[48] E. Woodle,et al. Posttransplant lymphoproliferative disorder: significance of central nervous system involvement. , 2005, Transplantation proceedings.
[49] E. Wijdicks,et al. Sirolimus may not cause neurotoxicity in kidney and liver transplant recipients , 2004, Neurology.
[50] D. Mutimer,et al. Fulminant liver failure due to severe veno-occlusive disease after haematopoietic cell transplantation: a depressing experience. , 2004, QJM : monthly journal of the Association of Physicians.
[51] F. Fattapposta,et al. Reversible diffusion MRI abnormalities and transient mutism after liver transplantation , 2004, Neurology.
[52] J. Gornbein,et al. A model to predict the development of mental status changes of unclear cause after liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[53] P. Howdle,et al. Neurologic complications of liver transplantation in adults , 2003, Neurology.
[54] D. Couriel,et al. Tacrolimus‐associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation , 2003, British journal of haematology.
[55] R. Lanciotti,et al. Transmission of West Nile virus from an organ donor to four transplant recipients. , 2003, The New England journal of medicine.
[56] E. Wijdicks,et al. OKT3 neurotoxicity presenting as akinetic mutism , 2003, Transplantation.
[57] A. Straube,et al. Prospective evaluation of neurological complications after allogeneic bone marrow transplantation , 2003, Neurology.
[58] R. Wiesner,et al. Acute confusional state following liver transplantation for alcoholic liver disease , 2002, Neurology.
[59] M. Seeck,et al. Seizure-like phenomena and propofol: A systematic review , 2002, Neurology.
[60] J. Biller,et al. Contrasting the Neurologic Complications of Cardiac Transplantation in Adults and Children , 2002, Journal of child neurology.
[61] C. Lampl,et al. Central Pontine Myelinolysis , 2002, European Neurology.
[62] T. Beresford. Neuropsychiatric complications of liver and other solid organ transplantation , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[63] S. Terae,et al. MRI in seven cases of tacrolimus (FK-506) encephalopathy: utility of FLAIR and diffusion-weighted imaging , 2001, Neuroradiology.
[64] W. Bechstein,et al. Neurotoxicity of calcineurin inhibitors: impact and clinical management , 2000, Transplant international : official journal of the European Society for Organ Transplantation.
[65] R Fischer,et al. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? , 2000, Journal of hepatology.
[66] T. Gruenberger,et al. Organ survival after primary dysfunction of liver grafts in clinical orthotopic liver transplantation , 2000, Transplant international : official journal of the European Society for Organ Transplantation.
[67] J. Z. Neto,et al. Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases , 2000, Bone Marrow Transplantation.
[68] Charles M. Miller,et al. Central nervous system complications in liver transplant recipients – incidence, timing, and long‐term follow‐up , 2000, Clinical transplantation.
[69] M. J. van den Bent,et al. Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donors , 2000, Journal of neurology, neurosurgery, and psychiatry.
[70] M. L. Zanotelli,et al. Neurological complications in liver transplantation. , 1999, Transplantation proceedings.
[71] J. Jörg,et al. Outcome of central pontine and extrapontine myelinolysis (n = 44) , 1999, Journal of Neurology.
[72] M. J. van den Bent,et al. Cyclosporine neurotoxicity: a review , 1999, Journal of Neurology.
[73] G. Decaux,et al. Therapeutic relowering of the serum sodium in a patient after excessive correction of hyponatremia. , 1999, Clinical nephrology.
[74] R. Wiesner,et al. Oral cyclosporine decreases severity of neurotoxicity in liver transplant recipients , 1999, Neurology.
[75] J. Reyes,et al. The neuropathology of intestinal failure and small bowel transplantation , 1999, Acta Neuropathologica.
[76] Nina Singh,et al. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. , 1999, Transplantation.
[77] Seung‐Kyu Chung,et al. Calcification in chronic maxillary sinusitis: comparison of CT findings with histopathologic results. , 1999, AJNR. American journal of neuroradiology.
[78] Prayson Ra,et al. The neuropathology of orthotopic liver transplantation: an autopsy series of 16 patients. , 1998 .
[79] G. Klintmalm,et al. Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis. , 1998, Clinical transplantation.
[80] W. Arcese,et al. Early neurologic complications following allogeneic bone marrow transplant for leukemia , 1998, Neurology.
[81] T. Chauncey,et al. Neuroleptic malignant syndrome following autologous peripheral blood stem cell transplantation , 1998, Bone Marrow Transplantation.
[82] A. Mehta,et al. Central nervous system complications after lung transplantation. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[83] Nina Singh,et al. Interactions between tacrolimus and antimicrobial agents. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[84] S. Werlin,et al. Hyperammonemic encephalopathy after chemotherapy. Survival after treatment with sodium benzoate and sodium phenylacetate. , 1997, Journal of clinical gastroenterology.
[85] E. van Marck,et al. Cerebral complications of murine monoclonal CD3 antibody (OKT3): CT and MR findings. , 1997, AJNR. American journal of neuroradiology.
[86] E. Deya,et al. Persistent cortical blindness after cyclosporine leukoencephalopathy. , 1997, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[87] G. Sette,et al. Reply from the Authors , 1997, Neurology.
[88] R. Wiesner,et al. Causes and outcome of seizures in liver transplant recipients , 1996, Neurology.
[89] T. Dawson,et al. Immunosuppressants, immunophilins, and the nervous system , 1996, Annals of neurology.
[90] L Timmermann,et al. The mechanism of action of cyclosporin A and FK506. , 1996, Clinical immunology and immunopathology.
[91] L R Caplan,et al. A reversible posterior leukoencephalopathy syndrome. , 1996, The New England journal of medicine.
[92] J. Wagner,et al. Idiopathic hyperammonemia: a frequently lethal complication of bone marrow transplantation. , 1996, Bone marrow transplantation.
[93] K. Goa,et al. Muromonab CD3 , 1996, Drugs.
[94] E. Tolosa,et al. Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia , 1996, Neurology.
[95] R. Wiesner,et al. Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression , 1995, Neurology.
[96] M. Schwartz,et al. Loss of speech after orthotopic liver transplantation , 1995, Transplant international : official journal of the European Society for Organ Transplantation.
[97] U. de Girolami,et al. Neuropathology of liver transplantation. , 1995, Clinical neuropathology.
[98] J Hennig,et al. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. , 1994, Gastroenterology.
[99] J. Dasta,et al. Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: A review of the literature , 1994, Critical care medicine.
[100] R. Wiesner,et al. FK506‐induced neurotoxicity in liver transplantation , 1994, Annals of neurology.
[101] Nina Singh,et al. Central Nervous System Lesions in Adult Liver Transplant Recipients: Clinical Review with Implications for Management , 1994, Medicine.
[102] M. Pinsky,et al. Postreperfusion syndrome: hypotension after reperfusion of the transplanted liver. , 1993, Journal of critical care.
[103] W. Bennett,et al. Cytokine-related encephalopathy induced by OKT3: incidence and predisposing factors. , 1993, Transplantation proceedings.
[104] M. Rosenblum,et al. Amphotericin B‐associated leukoencephalopathy , 1992, Neurology.
[105] Á. Figuera,et al. High dose busulfan and seizures. , 1991, Bone marrow transplantation.
[106] T. Bunchman,et al. Smooth muscle cell proliferation by conditioned media from cyclosporine-treated endothelial cells: a role of endothelin. , 1991, Transplantation proceedings.
[107] Y. Archibald,et al. The encephalopathy associated with septic illness. , 1990, Clinical and investigative medicine. Medecine clinique et experimentale.
[108] G. B. Young,et al. The significance of myoclonic status epilepticus in postanoxic coma , 1990, Neurology.
[109] R. Marcus,et al. Veno-occlusive disease of the liver complicating ABMT successfully treated with recombinant tissue plasminogen activator (rt-PA). , 1990, Bone marrow transplantation.
[110] W. Savage,et al. GYNAECOLOGISTS' ATTITUDES TO ABORTION , 1989, The Lancet.
[111] Z. Wszolek,et al. Pontine and extrapontine myelinolysis following liver transplantation. Relationship to serum sodium. , 1989, Transplantation.
[112] C. Estol,et al. Central pontine myelinolysis after liver transplantation , 1989, Neurology.
[113] L. Lange,et al. Cyclosporin neurotoxicity in cardiac transplant recipients. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[114] J. Whisnant,et al. Central pontine myelinolysis and its imitators: MR findings. , 1988, Radiology.
[115] G. Forbes,et al. Central Nervous System Toxicity after Liver Transplantation , 1987 .
[116] D. Adams,et al. NEUROLOGICAL COMPLICATIONS FOLLOWING LIVER TRANSPLANTATION , 1987, The Lancet.
[117] Alan C. Evans,et al. Akinetic mutism in a bone marrow transplant recipient following total-body irradiation and amphotericin B chemoprophylaxis. A positron emission tomographic and neuropathologic study. , 1987, Archives of neurology.
[118] D. Back,et al. CYCLOSPORIN METABOLITES AND NEUROTOXICITY , 1986, The Lancet.
[119] A. Keyser,et al. SEVERE CENTRAL-NERVOUS-SYSTEM TOXICITY ASSOCIATED WITH CYCLOSPORIN , 1985, The Lancet.
[120] A. Laupacis,et al. Interaction between phenytoin and cyclosporine following organ transplantation. , 1984, Transplantation.
[121] C. Perreault,et al. Acute graft-versus-host disease after allogeneic bone marrow transplantation. , 1983, Canadian Medical Association journal.
[122] Y. Naot,et al. Primary and reactivated toxoplasma infection in patients with cardiac transplants. Clinical spectrum and problems in diagnosis in a defined population. , 1983, Annals of internal medicine.
[123] A. Arieff,et al. Uremic encephalopathies: clinical, biochemical, and experimental features. , 1982, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[124] D. Wright,et al. Pontine and extrapontine myelinolysis. , 1979, Brain : a journal of neurology.
[125] W. Orrison,et al. Central pontine myelinolysis Considerations on etiology, diagnosis, and treatment , 1979, Neurology.
[126] D. Dunn,et al. CYCLOSPORIN A IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM CADAVER DONORS , 1978, The Lancet.
[127] T. Starzl,et al. Acute Neurological Complications After Liver Transplantation with Particular Reference to Intraoperative Cerebral Air Embolus , 1978, Annals of surgery.
[128] P. Jonescu. Letter: Herpes simplex encephalitis. , 1974, Lancet.
[129] Godber Ge. Letter: Fluoride toxicity. , 1973, Lancet.
[130] R. Adams,et al. Central Pontine Myelinolysis: A Hitherto Undescribed Disease Occurring in Alcoholic and Malnourished Patients , 1959 .
[131] G. Young,et al. Perioperative Neurological Complications After Liver Transplantation are Best Predicted by Pre-transplant Hepatic Encephalopathy , 2008, Neurocritical care.
[132] C. Broelsch,et al. Severe neurological events following liver transplantation. , 2007, Archives of medical research.
[133] N. Chao,et al. Prophylaxis and treatment of acute graft-versus-host disease. , 2006, Seminars in hematology.
[134] K. Sullivan,et al. Polymyositis as a manifestation of chronic graft-versus-host disease. , 2003, Rheumatology.
[135] R. Wiesner,et al. Central pontine myelinolysis with stupor alone after orthotopic liver transplantation. , 1996, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[136] R. Prayson,et al. The neuropathology of cardiac allograft transplantation. An autopsy series of 18 patients. , 1995, Archives of pathology & laboratory medicine.
[137] A. Collins,et al. Humanization of the murine anti-human CD3 monoclonal antibody OKT3. , 1994, Human antibodies and hybridomas.
[138] A. Lindholm,et al. Cyclosporin metabolism in human liver microsomes and its inhibition by other drugs. , 1990, Pharmacology & toxicology.
[139] H. Deeg,et al. Graft-versus-host disease: pathophysiological and clinical aspects. , 1984, Annual review of medicine.